FDA issued a Warning Letter to Nostrum Laboratories Inc on 4/27/2009 for a later inspection.
483 Nostrum Labs Apr 2005

483 Nostrum Labs Apr 2005

Shirley Berryman FDA, Danial Hutchison FDA, Michele Obert FDA, Raymond Valdivia FDA$119.00 - Available Now

FDA investigators audited the Nostrum Labs - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 08 Apr 2005.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Apr 2005
  • Location: Kansas City, United States
  • FEI: 1930436
Add To Cart